Akt activity in Alzheimer’s disease and other neurodegenerative disorders
- 1 April 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in NeuroReport
- Vol. 15 (6), 955-959
- https://doi.org/10.1097/00001756-200404290-00005
Abstract
Enzyme activities of the serine/threonine kinase Akt were compared in mid-temporal and mid-frontal cortices from Alzheimer's disease cases and matched controls. Activities (GSK-3alpha/beta fusion protein phosphorylation by immunoprecipitated Akt) were significantly increased in temporal cortex soluble fractions from Alzheimer's disease compared with non-disease controls and positive disease controls with another neurodegenerative disease. Temporal cortex soluble fraction Akt activities positively correlated with Braak staging for neurofibrillary changes. Frontal cortex soluble fraction activities were significantly reduced in positive disease compared with Alzheimer's disease cases and non-disease controls. Strong Ser Akt immunoreactivity was seen in Alzheimer's disease pyramidal neurons likely undergoing degeneration and in reactive astroglia. Non-disease and positive disease controls showed moderate Ser Akt immunostaining of occasional pyramidal neurons.Keywords
This publication has 12 references indexed in Scilit:
- FRAT1 peptide decreases Aβ production in swAPP751 cellsFEBS Letters, 2003
- GSK-3α regulates production of Alzheimer's disease amyloid-β peptidesNature, 2003
- GSK3β Signalling: Casting a Wide Net in Alzheimer’s DiseaseNeurosignals, 2002
- Ten years of protein kinase B signalling: a hard Akt to followTrends in Biochemical Sciences, 2001
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingProgress in Neurobiology, 2001
- Protective and Rescuing Abilities of IGF‐I and Some Putative Free Radical Scavengers against β‐Amyloid‐Inducing Toxicity in NeuronsAnnals of the New York Academy of Sciences, 1999
- Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary ChangesJournal of Neuropathology and Experimental Neurology, 1999
- Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawalJournal of Neurobiology, 1998
- Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neuronsNeuroscience Research, 1998
- Distribution, Levels, and Activity of Glycogen Synthase Kinase-3 in the Alzheimer Disease BrainJournal of Neuropathology and Experimental Neurology, 1997